Synthesis and structure-activity relationships of 5-phenylthiophenecarboxylic acid derivatives as antirheumatic agents

被引:17
|
作者
Noguchi, T [1 ]
Hasegawa, M [1 ]
Tomisawa, K [1 ]
Mitsukuchi, M [1 ]
机构
[1] Taisho Pharmaceut Co Ltd, Med Res Labs, Kita Ku, Saitama 3308530, Japan
关键词
D O I
10.1016/j.bmc.2003.08.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
5-(Phenylthiophene)-3-carboxylic acid (2a), a metabolite of esonarimod (1), which was developed as a new antirheumatic drug, was considered as a lead compound for new antirheumatic drugs. A new series of 2a derivatives were synthesized and their characteristic pharmacological effects, that is their antagonistic effect toward interleukin (IL)-1 in mice and the suppressive effect against adjuvant-induced arthritis (AIA) in rats, were evaluated and compared with those of 1. The structure-activity relationships indicated that [5-(4-bromophenyl)- thiophen-3-yl]acetic acid (5d), methyl [5-(4-chlorophenyl)-thiophen-3-yl]acetate acid (5d), and methyl [5-(4-bromophenyl)-thiophen-3-yl]acetate (5i) suppressed AIA more potently than 1 and all of the other synthesized compounds. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4729 / 4742
页数:14
相关论文
共 50 条
  • [1] Chemometric Modeling of 5-Phenylthiophenecarboxylic Acid Derivatives as Anti-Rheumatic Agents
    Adhikari, Nilanjan
    Jana, Dhritiman
    Halder, Amit K.
    Mondal, Chanchal
    Maiti, Milan K.
    Jha, Tarun
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2012, 8 (03) : 182 - 195
  • [2] Synthesis and structure-activity relationships of oxadiazolidinedione derivatives as hypoglycemic agents.
    Suzuki, T
    Niigata, K
    Takahashi, T
    Maruyama, T
    Onda, K
    Noshiro, O
    Isomura, Y
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U873 - U873
  • [3] Synthesis and structure-activity relationships of harmine derivatives as potential antitumor agents
    Cao, Rihui
    Fan, Wenxi
    Guo, Liang
    Ma, Qin
    Zhang, Guoxian
    Li, Jianru
    Chen, Xuemei
    Ren, Zhenghua
    Qiu, Liqin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 60 : 135 - 143
  • [4] Structure-activity relationships of silybin derivatives as anticancer agents
    Vue, Bao
    Zhang, Sheng
    Parisis, Konstantinos
    Chen, Qiaohong
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [5] Synthesis and structure-activity relationships of sinenxan A derivatives as multidrug resistance reversal agents
    Huang, Meng
    Zhao, Xin
    Zhang, Meng
    Gu, Jun
    Chen, Xiaoguang
    Yin, Dali
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (18) : 5418 - 5421
  • [6] Benzoylurea derivatives as a novel class of antimitotic agents: Synthesis, anticancer activity, and structure-activity relationships
    Song, Dan-Qing
    Wang, Yan
    Wu, Lian-Zong
    Yang, Peng
    Wang, Yue-Ming
    Gao, Li-Mei
    Li, Yan
    Qu, Jing-Rong
    Wang, Yong-Hong
    Li, Ying-Hong
    Du, Na-Na
    Han, Yan-Xing
    Zhang, Zhi-Ping
    Jiang, Jian-Dong
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (11) : 3094 - 3103
  • [7] Synthesis, anticholinesterase activity and structure-activity relationships of m-aminobenzoic acid derivatives
    Trujillo-Ferrara, J
    Cano, LM
    Espinoza-Fonseca, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (10) : 1825 - 1827
  • [8] Novel benzoylurea derivatives as potential antitumor agents; Synthesis, activities and structure-activity relationships
    Hwang, KJ
    Park, KH
    Lee, CO
    Kim, BT
    ARCHIVES OF PHARMACAL RESEARCH, 2002, 25 (06) : 781 - 785
  • [9] Synthesis and structure-activity relationships of asymmetric dimeric β-carboline derivatives as potential antitumor agents
    Guo, Liang
    Chen, Wei
    Cao, Rihui
    Fan, Wenxi
    Ma, Qin
    Zhang, Jie
    Dai, Bin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 147 : 253 - 265
  • [10] Novel benzoylurea derivatives as potential antitumor agents; synthesis, activities and structure-activity relationships
    Ki -Jun Hwang
    Kyung -Ho Park
    Chong -Ock Lee
    Beom -Tae Kim
    Archives of Pharmacal Research, 2002, 25 : 781 - 785